Home/Filings/4/0001209191-19-018398
4//SEC Filing

MCAFEE LAWRANCE W 4

Accession 0001209191-19-018398

CIK 0000885978other

Filed

Mar 10, 8:00 PM ET

Accepted

Mar 11, 4:07 PM ET

Size

5.5 KB

Accession

0001209191-19-018398

Insider Transaction Report

Form 4
Period: 2019-03-08
MCAFEE LAWRANCE W
DirectorChief Financial Officer
Transactions
  • Sale

    Common Stock

    2019-03-08$106.43/sh3,150$335,25526,728 total
Footnotes (2)
  • [F1]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $105.00 to $107.04 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
  • [F2]Includes 24,898 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 2,500 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; 1,790 shares on each of April 1, July 1 and October 1, 2020; 1,805 shares on January 1, 2021; 1,280 shares on each of April 1, July 1 and October 1, 2021 and 1,288 shares on January 1, 2022; 648 on each of April 1, July 1 and October 1, 2022; and 651 on January 1, 2023.

Issuer

U S PHYSICAL THERAPY INC /NV

CIK 0000885978

Entity typeother

Related Parties

1
  • filerCIK 0001263096

Filing Metadata

Form type
4
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 4:07 PM ET
Size
5.5 KB